INR 2,000 Cr Investment Push Aims to Accelerate the Medicine Manufacturing Ecosystem in UP

By facilitating investor confidence through policy support and infrastructure readiness, the state government aims to attract long-term capital and technical expertise.

Uttar Pradesh has positioned itself to expand its footprint in medicine manufacturing with a proposed INR 2,000 crore investment, as CM Yogi Adityanath has distributed letters of comfort to pharma investors to catalyse sectoral growth and industrial development.

India’s pharmaceutical sector has emerged as a global leader over the past decade, supplying affordable and high-quality medicines to more than 200 countries. The country is widely recognized as the “pharmacy of the world,” driven by a strong generics market, cost-effective manufacturing, and increasing investments in research and development.

"This investment of approximately two thousand crores (rupees) will provide a new impetus to medicine manufacturing and medical device production. It will also contribute to providing the state significant heights in the field of research and development," he said.

"Due to this, skilled and unskilled manpower within the state, more than 10,000 youth will also be helped in joining it," he added.

Beyond employment, the investment aligns with broader national priorities such as reducing import dependency in critical healthcare products and enhancing domestic manufacturing under initiatives like “Make in India.”

Increased local production capacity is also expected to improve accessibility and affordability of medicines, particularly in underserved regions.

"India's economy has touched new heights. Even in the pharmaceutical sector, India has succeeded in providing affordable and high-quality medicines to more than 200 countries, and India has achieved rapid success in that direction," he said.

He further noted, "As India's most populous state, Uttar Pradesh had this potential, but it lacked the necessary groundwork. I am pleased that today the results of a collective effort in this field are being seen on the ground.”

The initiative is expected to create a ripple effect across the healthcare manufacturing ecosystem, strengthening supply chains and encouraging innovation in both pharmaceuticals and medical devices.

By facilitating investor confidence through policy support and infrastructure readiness, the state government aims to attract long-term capital and technical expertise.

Stay tuned for more such updates on Digital Health News